Page 1 of Clinical Trials for VePesid, 959 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Not yet recruiting
Efficacy and Safety of Obatoclax Mesylate in Combination With Carboplatin and Etoposide Compared With Carboplatin and Etoposide Alone in Chemotherapy-Naive Patients With Extensive-Stage Small Cell Lung Cancer
Last Updated: May 10, 2012
Condition(s): Extensive-stage Small Cell Lung Cancer
2
Active, not recruiting
Phase III Further Retrospect Clinical Study for FDA IND Exemption - Etoposide and Single Nucleotide Polymorphisms
Last Updated: April 20, 2012
Condition(s): Small Cell Lung Cancer
3
Active, not recruiting
Ph I Dose Escalation Trial of Vandetanib in Combo w Etoposide for Malignant Gliomas
Last Updated: February 17, 2012
Condition(s): Gliosarcoma; Glioblastoma
4
Active, not recruiting
Ph II Bev + Either Temozolomide/Etoposide for GBM Pts Who Have Failed Bev + Irinotecan
Last Updated: December 26, 2008
Condition(s): Glioblastoma; Gliosarcoma
5
Recruiting
Bendamustine in Combination With Ofatumumab, Carboplatin and Etoposide for Refractory or Relapsed Aggressive B-Cell Lymphomas
Last Updated: January 3, 2012
Condition(s): Non-Hodgkin's Lymphoma
6
Active, not recruiting
Ph II Bevacizumab + Etoposide for Pts w Recurrent MG
Last Updated: August 4, 2009
Condition(s): Glioblastoma; Gliosarcoma
7
Terminated
Phase 2 Study of Trastuzumab and Etoposide for Her2 Positive Breast Cancer
Last Updated: November 4, 2011
Condition(s): HER-2 Positive Metastatic Breast Cancer
8
Completed
Recombinant Interferon Alpha and Etoposide in Relapsed Osteosarcoma
Last Updated: June 20, 2011
Condition(s): Osteosarcoma
9
Terminated
Carboplatin and Etoposide Plus LBH589 for Small Cell Lung Cancer
Last Updated: January 6, 2012
Condition(s): Small Cell Lung Cancer
10
Recruiting
Trial in Extensive-Disease Small Cell Lung Cancer (ED-SCLC) Subjects Comparing Ipilimumab Plus Etoposide and Platinum Therapy to Etoposide and Platinum Therapy Alone
Last Updated: April 30, 2012
Condition(s): Small Cell Lung Carcinoma
11
Recruiting
Randomized Study of Cisplatin-Etoposide Versus an Etoposide Regimen Without Cisplatin in Extensive Small-Cell Lung Cancer
Last Updated: June 22, 2011
Condition(s): Small Cell Lung Carcinoma, Extensive Disease
12
Suspended
Clofarabine, Etoposide, and Mitoxantrone for Relapsed and Refractory Acute Leukemias
Last Updated: July 19, 2011
Condition(s): Leukemia
13
Active, not recruiting
Valproate and Etoposide for Patients With Neuronal Tumors and Brain Metastases
Last Updated: November 14, 2011
Condition(s): Neuroectodermal Tumor; Brain Metastases; Advanced Cancer
14
Suspended
GCS-100 in Combination With Etoposide and Dexamethasone in Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Last Updated: May 15, 2009
Condition(s): Diffuse Large B-Cell Lymphoma, Relapsed or Refractory
15
Recruiting
A Study of BMS-833923 With Carboplatin and Etoposide Followed by BMS-833923 Alone in Subjects With Extensive-Stage Small Cell Lung Cancer
Last Updated: April 30, 2012
Condition(s): Small Cell Lung Carcinoma
16
Active, not recruiting
Busulfan and Etoposide Followed by Peripheral Blood Stem Cell Transplant and Low-Dose Aldesleukin in Treating Patients With Acute Myeloid Leukemia
Last Updated: July 21, 2011
Condition(s): Adult Acute Myeloid Leukemia in Remission; Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities; Adult Acute Myeloid Leukemia With Del(5q); Adult Acute Myeloid Leukemia With t(15;17)(q22;q12); Adult Acute Myeloid Leukemia With t(16;16)(p13;q22); Childhood Acute Myeloid Leukemia in Remission; Recurrent Adult Acute Myeloid Leukemia; Recurrent Childhood Acute Myeloid Leukemia
17
Recruiting
Carboplatin and Etoposide in Combination With Vorinostat for Patients With Extensive Stage Small Cell Lung Cancer
Last Updated: July 19, 2011
Condition(s): Small Cell Lung Cancer
18
Recruiting
Safety Study for Refractory or Relapsed Neuroblastoma With DFMO Alone and in Combination With Etoposide
Last Updated: April 13, 2012
Condition(s): Neuroblastoma
19
Active, not recruiting
Busulfan, Etoposide, and Intensity-Modulated Radiation Therapy Followed By Donor Stem Cell Transplant in Treating Patients With Advanced Myeloid Cancer
Last Updated: May 18, 2012
Condition(s): Adult Acute Myeloid Leukemia in Remission; Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities; Adult Acute Myeloid Leukemia With Del(5q); Adult Acute Myeloid Leukemia With Inv(16)(p13;q22); Adult Acute Myeloid Leukemia With t(15;17)(q22;q12); Adult Acute Myeloid Leukemia With t(16;16)(p13;q22); Adult Acute Myeloid Leukemia With t(8;21)(q22;q22); Blastic Phase Chronic Myelogenous Leukemia; Childhood Acute Myeloid Leukemia in Remission; Childhood Chronic Myelogenous Leukemia; Childhood Myelodysplastic Syndromes; Previously Treated Myelodysplastic Syndromes; Recurrent Adult Acute Myeloid Leukemia; Recurrent Childhood Acute Myeloid Leukemia; Refractory Anemia With Excess Blasts
20
Recruiting
Oxaliplatin, Ifosfamide and Etoposide in Treating Young Patients With Recurrent or Refractory Solid Tumors or Lymphoma
Last Updated: December 7, 2011
Condition(s): Solid Tumors; Lymphomas

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=VePesid

Page 1 of Clinical Trials for VePesid, 959 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About